Healthcare -
Biotechnology - NASDAQ - BM
$ 19.98
0.503 %
$ 1.44 B
Market Cap
-166.5
P/E
KNSA - TOTAL LIABILITIES & EQUITY
Total Liabilities & Equity KNSA - Kiniksa Pharmaceuticals, Ltd.
526 M
LAST VALUE
68.48%
2 YEAR CAGR
40.49%
5 YEAR CAGR
0.00%
10 YEAR CAGR